The Administration Takes Aim At Drug Prices Again – This Time Through A Controversial Framework for Exercising March-In Rights | King & Spalding
The Biden Administration recently announced a plan to leverage an old tool in a new way to try to reduce drug costs: exercising “march-in rights” under the Bayh-Dole Act for drugs that ...
Source: jdsupra.com